EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MORC3 represses the HCMV major immediate early promoter in myeloid cells in the absence of PML nuclear bodies

Anna Champion, Alexandra Rowland, Levia Yee, Dick van den Boomen, Matthew Reeves, Paul Lehner, John Sinclair, Emma Poole

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.29227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Anna Champion und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Adenosine Triphosphatases, Cytomegalovirus Infections, DNA-Binding Proteins, Promyelocytic Leukemia Nuclear Bodies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human cytomegalovirus (HCMV) can undergo either a latent or a lytic infection in cells of the myeloid lineage. Whilst the molecular mechanisms which determine the outcome of infection are far from clear, it is well established that a key factor is the differential regulation of the major immediate early promoter (MIEP) responsible for driving lytic immediate early gene expression. Using a myelomonocytic cell line stably transduced with a GFP reporter under the control of the MIEP, which recapitulates MIEP regulation in the context of virus infection, we have used an unbiased CRISPR‐Cas9 sub‐genomic, epigenetic library screen to identify novel cellular factors involved in MIEP repression during establishment and maintenance of latency in myeloid cells. One such cellular factor identified was MORC3. Consistent with MORC3 being a robust repressor of the MIEP, we show that THP1 cells devoid of MORC3 fail to establish latency. We also show that MORC3 is induced during latent infection, recruited to the MIEP and forms MORC3 nuclear bodies (MORC3‐NBs) which, interestingly, co‐localize with viral genomes. Finally, we show that the latency‐associated functions of MORC3 are regulated by the deSUMOylase activity of the viral latency‐associated LUNA protein likely to prevent untimely HCMV reactivation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenosine TriphosphatasesCytomegalovirus InfectionsDNA-Binding ProteinsPromyelocytic Leukemia Nuclear BodiesHumansCytomegalovirusGene Expression Regulation, ViralMyeloid CellsVirus Latency

Stichwörter der Autor:innen

MORC3human cytomegaloviruslatency

Substanzen

Adenosine TriphosphatasesDNA-Binding ProteinsMORC3 protein, human

Autor:innen und Institutionen

  • Department of Medicine, University of Cambridge, Cambridge, UK.
  • Divison of Virology, Department of Pathology, University of Cambridge, Cambridge, UK.
  • Department of Pathology, University of Cambridge, Cambridge, UK.

Förderung

  • Medical Research Council

Zitieren

APA

Champion, A., Rowland, A., Yee, L., van den Boomen, D., Reeves, M., Lehner, P., Sinclair, J., & Poole, E. (2023). MORC3 represses the HCMV major immediate early promoter in myeloid cells in the absence of PML nuclear bodies. Journal of Medical Virology. https://doi.org/10.1002/jmv.29227

Vancouver

Champion A, Rowland A, Yee L, van den Boomen D, Reeves M, Lehner P, et al. MORC3 represses the HCMV major immediate early promoter in myeloid cells in the absence of PML nuclear bodies. Journal of Medical Virology. 2023. doi:10.1002/jmv.29227

BibTeX
@article{Champion2023,
  author = {Champion, Anna and Rowland, Alexandra and Yee, Levia and van den Boomen, Dick and Reeves, Matthew and Lehner, Paul and Sinclair, John and Poole, Emma},
  title = {MORC3 represses the HCMV major immediate early promoter in myeloid cells in the absence of PML nuclear bodies},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.29227}
}
Kostenlos starten →